clinical trials all news related to

Chinese mpox vaccine gets green light for clinical trials

September 09, 2024

A domestic mpox vaccine candidate developed by Chinese drugmaker Sinopharm received clearance from the top drug regulator for clinical trials on Monday, representing the nation's first experimental dose to win the trial approval, said the company.

Cabinet nod for clinical trials on humans of plant-based Covid vaccine

April 13, 2022

The Cabinet on Tuesday approved the 2a phase of the project to study the immunogenicity and efficiency of plant-based Baiya Covid-19 vaccine on humans at a cost of THB211 million.

AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient treatment trial

TUESDAY, OCTOBER 12, 2021

Positive high-level results from the TACKLE Phase III COVID-19 treatment trial showed AstraZenecas AZD7442, a long-acting antibody (LAAB) combination, achieved a statistically significant reduction in severe COVID-19 or death compared to placebo in non-hospitalised patients with mild-to-moderate symptomatic COVID-19.

S. Korea’s hope for normalization boosted with positive trial results from Merck

SUNDAY, OCTOBER 03, 2021

South Korea’s plan to step into a phased recovery back to normal life in November is gaining support with positive clinical test results of an experimental COVID-19 oral medication overseas.

Chulalongkorn Hospital seeking older volunteers for mRNA vaccine trial

WEDNESDAY, AUGUST 04, 2021

Chulalongkorn University’s Faculty of Medicine is seeking healthy volunteers for human trials of its ChulaCov19 vaccine in elderly people. To be eligible, volunteers must be 56-75 years old with no underlying disease and never have been infected with Covid-19 or vaccinated.

Researchers identify 21 existing drugs that could treat Covid-19

SUNDAY, JULY 26, 2020

Researchers are currently testing all 21 compounds in small animal models and “mini lungs,” or lung organoids, that mimic the human tissue.